Autologous Cell Therapy
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
67
NCT02551679
ACP-01 in Patients With Critical Limb Ischemia
Phase: Phase 2
Role: Lead Sponsor
Start: Aug 31, 2014
Completion: Apr 30, 2021
Loading map...